Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Cyprus
Montenegro
Czech Republic
Denmark
Estonia
Spain
Kosovo
Lithuania
Latvia
Luxembourg
Macedonia
Germany
Poland
Portugal
Romania
Serbia
Slovakia
Slovenia
Switzerland
Sweden
Turkey
Hungary
United Kingdom
Italy
UAE
Hong Kong
Kuwait
Lebanon
South Africa
Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 2001 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 68 |
| 2002 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 62 |
| 2003 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 48 |
| 2004 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 63 |
| 2005 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Spain | 58 |
| 2006 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 41 |
| 2007 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | USA | 73 |
| 2008 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
| 2009 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 65 |
| 2010 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
| 2011 | Apheresis | Allogeneic | Plasmacytoma | Hematology | 2024 | Standard Therapy | Poland | 46 |
| 2012 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Portugal | 60 |
| 2013 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Portugal | 60 |
| 2014 | Skeletal Muscle | Allogeneic – Related | Duchenne Muscular Dystrophy (DMD) | Genetic disorder | 2023 | Experimental Therapy | Poland | 8 |
| 2015 | Skeletal Muscle | Allogeneic – Related | Duchenne Muscular Dystrophy (DMD) | Genetic disorder | 2023 | Experimental Therapy | Poland | 16 |
| 2016 | Cord Tissue | Allogeneic – Related | Ags (Autism + Epilepsy) | Neurology | 2023 | Experimental Therapy | Poland/Romania | 15 |
| 2017 | Cord Tissue | Allogeneic – Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 8 |
| 2018 | Cord Tissue | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 10 |
| 2019 | Cord Tissue | Allogeneic – Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 4 |
| 2020 | Cord Tissue | Allogeneic – Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 2021 | Cord Tissue | Allogeneic – Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3 |
| 2022 | Cord Tissue | Autologous | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 2 |
| 2023 | Cord Tissue | Allogeneic – Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 3 |
| 2024 | Cord Tissue | Allogeneic – Unrelated | Disorders Of Optic Nerve | Ophthalmology | 2023 | Experimental Therapy | Poland | 39 |
| 2025 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2023 | Experimental Therapy | Poland | 65 |
| 2026 | Cord Tissue | Allogeneic – Unrelated | Gonarthrosis | Orthopedy | 2023 | Experimental Therapy | Poland | 50 |
| 2027 | Cord Tissue | Allogeneic – Unrelated | Graft Versus Host Disease | Hematology | 2023 | Experimental Therapy | Poland | 8 |
| 2028 | Cord Tissue | Allogeneic – Unrelated | Graft Versus Host Disease | Hematology | 2023 | Experimental Therapy | Poland | 16 |
| 2029 | Cord Tissue | Allogeneic – Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 20 |
| 2030 | Cord Tissue | Allogeneic – Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 49 |
| 2031 | Cord Tissue | Allogeneic – Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 62 |
| 2032 | Cord Tissue | Allogeneic – Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 24 |
| 2033 | Cord Tissue | Allogeneic – Unrelated | Mucopolysaccharidosis Type Ii | Hematology | 2023 | Experimental Therapy | Poland | 4 |
| 2034 | Cord Tissue | Allogeneic – Unrelated | Non-Inflammatory Diseases Of The Ovary, Fallopian Tube, And Broad Ligament Of The Uterus | Gynecology | 2023 | Experimental Therapy | Poland | 47 |
| 2035 | Cord Tissue | Autologous | Optic Nerve Atrophy, Tetraparesis, Hydrocephalus | Neurology | 2023 | Experimental Therapy | Romania | 5 |
| 2036 | Cord Tissue | Allogeneic – Unrelated | Ovarian Dysfunction | Gynecology | 2023 | Experimental Therapy | Poland | 44 |
| 2037 | Cord Tissue | Allogeneic – Unrelated | Ovarian Dysfunction | Gynecology | 2023 | Experimental Therapy | Poland | 32 |
| 2038 | Cord Tissue | Allogeneic – Unrelated | Polycystic Ovary Syndrome | Gynecology | 2023 | Experimental Therapy | Poland | 39 |
| 2039 | Cord Tissue | Allogeneic – Related | Right Parietal Closed Schizencephaly | Neurology | 2023 | Experimental Therapy | Romania | 38 |
| 2040 | Cord Tissue | Allogeneic – Related | Rp+ Usher Syndrome | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 2041 | Cord Tissue | Allogeneic – Related | Sudden Sensorineural Hearing Loss (Ssnhl) | Neurology | 2023 | Experimental Therapy | Romania | 1 |
| 2042 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 10 |
| 2043 | Cord Blood | Allogeneic | Autism | Neurology | 2023 | Experimental Therapy | Poland | 3 |
| 2044 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3 |
| 2045 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3 |
| 2046 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 2047 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Portugal | 7 |
| 2048 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Portugal | 5 |
| 2049 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 14 |
| 2050 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 2051 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 3 |
| 2052 | Cord Blood | Allogeneic – Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3 |
| 2053 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 5 |
| 2054 | Cord Blood | Allogeneic – Related | Beta Thalassemia | Hematology | 2023 | Standard Therapy | UK | 8 |
| 2055 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Hungary | 5 |
| 2056 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2023 | Standard Therapy | UK | 2 |
| 2057 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2023 | Standard Therapy | UK | 2 |
| 2058 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Poland | 2 |
| 2059 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 10 |
| 2060 | Cord Blood | Allogeneic – Related | Cerebral Palsy, Psychomotor Retard, Tetraparesis, Microcephaly | Neurology | 2023 | Experimental Therapy | Romania | 9 |
| 2061 | Cord Blood | Autologous | Global Developmental Delay Si Truncal Ataxia | Neurology | 2023 | Experimental Therapy | Romania | 5 |
| 2062 | Cord Blood | Allogeneic | Neuroblastoma | Hematology | 2023 | Standard Therapy | Turkey | 2 |
| 2063 | Cord Blood | Allogeneic – Related | Neuroblastoma | Hematology | 2023 | Standard Therapy | Turkey | 2 |
| 2064 | Cord Blood | Autologous | Optic Nerve Atrophy, Tetraparesis, Hydrocephalus | Neurology | 2023 | Experimental Therapy | Romania | 5 |
| 2065 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2023 | Experimental Therapy | Poland | 3 |
| 2066 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2023 | Experimental Therapy | Poland | 8 |
| 2067 | Cord Blood | Allogeneic – Related | Spasmodic Torticollis | Neurology | 2023 | Experimental Therapy | Romania | 41 |
| 2068 | Cord Blood | Allogeneic | Thalassemia Major | Hematology | 2023 | Standard Therapy | Turkey | 17 |
| 2069 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2023 | Standard Therapy | Turkey | 17 |
| 2070 | Cord Blood | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 5 |
| 2071 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Slovakia | 2 |
| 2072 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 2073 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
| 2074 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 35 |
| 2075 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 2076 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
| 2077 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
| 2078 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
| 2079 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 2080 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 21 |
| 2081 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
| 2082 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 2083 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 39 |
| 2084 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
| 2085 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
| 2086 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
| 2087 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
| 2088 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 2089 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
| 2090 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
| 2091 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 56 |
| 2092 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 2093 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
| 2094 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
| 2095 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
| 2096 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
| 2097 | Bone Marrow Family | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 30 |
| 2098 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
| 2099 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
| 2100 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |